Schizophrenia

Total Page:16

File Type:pdf, Size:1020Kb

Load more

60464ournal ofNeurology, Neurosurgery, and Psychiatry 1996;61:604-613 J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.60.6.604 on 1 June 1996. Downloaded from NEUROEPIDEMIOLOGY Schizophrenia Mary Cannon, Peter Jones Psychiatric epidemiology is the study of the studies of time trends and outcome in schizo- distribution and causes of mental disorder in phrenia. Also, the commitment to a phenotype the population. Over the past 30 years based on symptoms in adult life may have progress in psychiatric epidemiology has been ignored an important developmental or life- slower than in other areas-for example, car- long dimension to the disorder. diovascular disease or cancer epidemiology, because of certain methodological problems SCHIZOPHRENIA AS A "RARE DISEASE" that are just now being overcome. In particular The low incidence (10-40 cases per 100 000 the epidemiology of schizophrenia has suffered per year) and relatively low lifetime prevalence from two major difficulties: uncertainty about (0 5%-1 %) of schizophrenia in the population how to define a case, and the relative rarity of have led to a reliance on case-control study schizophrenia in the population. designs in research. Chronic patients recruited from hospital wards are compared with volun- teer controls from the community and conse- Special methodological problems in quent problems of bias and confounding have schizophrenia epidemiology often led to unreplicated and contradictory WHAT IS A CASE findings. It seemed for a time that schizophre- The lack of physical signs or laboratory tests nia, already known as the "graveyard of neu- means that a diagnosis of schizophrenia is ropathologists",7 would also prove to be the based on evaluation of patients' self reported, undoing of epidemiologists. Over the past two subjective experiences. Until the late 1960s, decades, however, the application of advances there was a relatively loose definition of schizo- in case-control methodology to psychiatric phrenia and a good deal of diagnostic latitude epidemiology has led to more robust results.8 was allowed to individual psychiatrists. How- Also, cohort designs, for long thought too http://jnnp.bmj.com/ ever, a report published in 1972,' showed that costly and time consuming to use in schizo- the diagnostic habits of psychiatrists in the phrenia research, have made a "comeback". United States and United Kingdom differed to For the purposes of this review schizophre- an unacceptable degree, and led to the intro- nia refers to a recent, operational definition duction of strict operational diagnostic criteria such as CATEGO,9 ICD-10, DSM-III, DSM- for schizophrenia. The Diagnostic and III-R, or DSM-IV. Robust findings are those Statistical Manual DSM-III,2 published in from studies with an epidemiological design- 1980, reduced the reliance on symptoms alone that is, population based studies with well on September 29, 2021 by guest. Protected copyright. by incorporating an element of chronicity-six defined samples and appropriate controls. We months prior duration of symptoms and an aim to show how the findings from robust epi- upper age limit of 45 years for a first diagnosis demiological research can help to unravel the of schizophrenia. Since 1980 there have been complex aetiology of schizophrenia. two more restrictive revisions of this diagnostic system, DSM-III-R3 and DSM-IV,4 and the International Classification of Diseases, Geography Department of (ICD), the diagnostic system favoured by In 1978, a large multicentre study of schizo- Psychological European psychiatrists, has also undergone a phrenia was initiated by WHO the 10 country Medicine, Institute of similar "narrowing" process with the change study (also known as the Determinants of Psychiatry, Denmark Hill, London SE5 8AF, from ICD-9 to ICD-10.5 Outcome of Severe Mental Disorders Study), UK But has this process gone too far? Although to provide information about the incidence, M Cannon the restrictive diagnostic criteria have certainly course, and outcome of schizophrenia in dif- Department of increased the reliability of the diagnosis, they ferent cultures.10 Two case definitions of schiz- Psychiatry, University have not improved the validity of "DSM-IV" ophrenia were used: a clinical of Nottingham, broad, Duncan Macmillan or "ICD-10 schizophrenia".6 Recent family definition comprising ICD-9 schizophrenia House, Porchester studies indicate that a broader concept of and paranoid psychoses, and a narrow, restric- Road, Nottingham schizophrenia actually fits genetic models tive definition including only cases classified as NG3 6AA, UK P Jones more readily than a restrictive definition. In "nuclear" schizophrenia using the CATEGO 9 Correspondence to: addition, the frequent changes in diagnostic computer programme Figures 1A and B Dr Peter Jones. criteria have affected the comparability of show the incidence rates for both definitions. Cannon, _rones 605 J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.60.6.604 on 1 June 1996. Downloaded from Figure 1 (A) Incidence of 20 of non-affective psychosis was 0.7%.12 This CATEGO S narrow schiz- FA ophrenia with 95% confi- Cu discrepancy may be related to issues of sam- m pling, interview methodology, or actual dence intervals from eight 15 H centres in the WHO change over time and remains to be clarified Determinants of Outcome 0C) Study. (B) Incidence of 0 by future reports. CATEGO S, P, and 0 10i A major prevalence study of psychiatric broad schizophrenia with 0 morbidity carried out in the United Kingdom ._0a) 95% confidence limits from -0 between and found a eight centres in the WHO 5 April September 1993,13 determinants ofoutcome .5 prevalence rate of 0 4% for functional psy- study. Data from J7ablensky C- chosis among persons aged 16-64 living in pri- et. al.'0 vate households. This rate is even lower than 0 L that found in the national comorbidity survey 6oB but as 37% of those who screened positive for Cu B Cu co 5 psychosis refused a second diagnostic inter- 0 60_ view, the true prevalence may be higher.'4 At 0 4 0 present, it seems that the lifetime prevalence of 0 0 330 _ schizophrenia in the western world lies some- C- where between 0 4% and 1-4%, and may have C.) C 220 TI decreased over the past decade. T .5'a ,o- + i C "INCIDENCE" DATA v,\ Prevalence of schizophrenia can be influenced NX by factors such as change in treatment, change It 00A in mortality rate, and changes in the age and sex structure of the population, and therefore, examination of incidence rates may be more informative. Ideally, such studies should be based on community incidence samples but, as this is difficult to achieve, case registers and There is little variation between centres for hospital admission data are commonly used. narrowly defined schizophrenia with rates Eagles and Whalley'5 first reported a decline ranging only between 7 and 14/100 000, (fig in the diagnosis of schizophrenia among first 1A). Although the parsimonious conclusion admissions in Scotland between 1969 and would be that the rates for narrowly defined 1978. There have since been 14 papers exam- schizophrenia are the same, the confidence ining this issue in England,'6-'0 Scotland,"'3 intervals for these estimates were wide and Denmark,'425 New Zealand,'6 Canada,'7 there may not have been sufficient statistical Ireland,'8 the United States,'9 and the power to detect differences. Netherlands.30 Those based on national statis- The incidence rates for broadly defined tics have found a large (40%-50%) decline in schizophrenia do seem to vary between coun- first admission rates for schizophrenia during tries 16 to 42/100 000 per and 17 18 25 26 (range year), the 1970s and the 1980s. Findings http://jnnp.bmj.com/ the rates for centres in the developing world based on case register data have been less con- are about twice as high as those in the devel- sistent and indeed, two such studies, from oped world (fig 1B). Further studies of schizo- Camberwell"7 and Salford'8 in the United phrenia in the developing world are needed to Kingdom, actually found a slight increase in replicate and further investigate these interest- the incidence of schizophrenia during the ing findings, and the problem of mental health same period. Others have reported a decrease in the developing world can no longer remain a in first admission rates for schizophrenia low priority for funding agencies and govern- among female patients only." 2830 on September 29, 2021 by guest. Protected copyright. ments. On the whole, however, the variation The major question is whether the decrease in incidence rates for schizophrenia world noted in first admission rates corresponds to wide is very small compared with illnesses an actual decrease in the incidence of the con- such as ischaemic heart disease or cancer, dition. Many factors influence this apparent which are known to have major environmental "administrative decline" in schizophrenia: (1) risk factors. The introduction of more restrictive diagnos- tic criteria for schizophrenia may cause a shift to diagnoses such as "borderline states"24 or Time trends affective psychosis.'930 (2) The move to com- PREVALENCE DATA munity care over the past two decades could Two major prevalence studies of psychiatric have affected hospital admission rates.'7 (3) illness have been carried out in the United Clinicians have become more reluctant to States, which indicate a decrease in prevalence make a diagnosis of schizophrenia on the first of schizophrenia over one decade. The hospital admission,'4
Recommended publications
  • 6.5 X 10.5 Long Title.P65

    6.5 X 10.5 Long Title.P65

    Cambridge University Press 978-0-521-12102-6 - The Epidemiology of Schizophrenia Edited by Robin M. Murray, Peter B. Jones, Ezra Susser, Jim van Os and Mary Cannon Frontmatter More information The Epidemiology of Schizophrenia For the first time in one volume, an international team of leading researchers and practitioners have come together to provide a comprehensive, contemporary, epidemiological overview of this multifaceted and mysterious disorder and address some of the age-old questions it raises. What is the genetic contribution to schizophrenia? Do pregnancy and birth complications increase the risk for schizophrenia? Is the incidence of schizophrenia decreasing? Why is the rate higher among immigrants and in those born in cities? Controversial issues such as the validity of dimen- sional classifications of schizophrenia and the continuum between psychosis and ‘normality’ are explored in depth. Separate chapters are devoted to topics of particular relevance to schizophre- nia such as suicide, violence and substance abuse. Drawing together the findings from the social, genetic, developmental and classical epidemi- ology of schizophrenia, this text will prove an invaluable resource for both clinicians and researchers. Robin M. Murray is Professor of Psychiatry at the Institute of Psychiatry in London and heads the largest psychiatric research department in Europe. He has co-authored eight books and over 500 research publications and is on the editorial board of numerous journals. He was President of the Association of European Psychiatrists (1994–96). Peter B. Jones is Professor of Psychiatry, University of Cambridge. He is on the editorial board of Psychological Medicine. Ezra Susser is Chair of the Department of Epidemiology at the Joseph L.
  • Cannabis and Mental Illness

    Cannabis and Mental Illness

    Cannabis and Mental Illness Journal Articles: Causal association between cannabis and psychosis: examination of the evidence by Louise Arseneault, Mary Cannon, John Witton and Robin M. Murray in the British Journal of Psychiatry. On an individual level, cannabis use confers an overall twofold increase in the relative risk for later schizophrenia. At the population level, elimination of cannabis use would reduce the incidence of schizophrenia by approximately 8%, assuming a causal relationship. Cannabis use appears to be neither a sufficient nor a necessary cause for psychosis.Itis acomponentcause, partof a complex constellationoffactorsleading topsychosis. Cases of psychotic disorder could be prevented by discouraging cannabis use among vulnerable youths. Research is needed to understand the mechanisms by which cannabis causes psychosis. Psychiatric effects of cannabis by Andrew Johns in the British Journal of Psychiatry. An appreciable proportion of cannabis users report short-lived adverse effects, including psychotic states following heavy consumption, and regular users are at risk of dependence. People with major mental illnesses such as schizophrenia are especially vulnerable in that cannabis generally provokes relapse and aggravates existing symptoms. Health workers need to recognise, and respond to, the adverse effects of cannabis on mental health. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review by Theresa HM Moore, et al. in The Lancet. The evidence is consistent with the view that cannabis increases risk of psychotic outcomes independently of confounding and transient intoxication effects, although evidence for affective outcomes is less strong. The uncertainty about whether cannabis causes psychosis is unlikely to be resolved by further longitudinal studies such as those reviewed here.
  • Global Research Priorities for Youth Mental Health

    Global Research Priorities for Youth Mental Health

    Mei Cristina (Orcid ID: 0000-0002-6765-8064) Dooley Barbara (Orcid ID: 0000-0002-2139-8316) Malla Ashok (Orcid ID: 0000-0002-5863-4191) Manion Ian (Orcid ID: 0000-0002-5749-895X) Global research priorities for youth mental health Running title: Youth mental health research priorities Cristina Mei,1,2 Joanna Fitzsimons,1,2 Nicholas Allen,3 Mario Alvarez-Jimenez,1,2 G Paul Amminger,1,2 Vivienne Browne,1 Mary Cannon,4 Maryann Davis,5 Barbara Dooley,6 Ian B. Hickie,7 Srividya Iyer,8-11 Eóin Killackey,1,2 Ashok Malla,8-10 Ian Manion,11,12 Steve Mathias,11,13 Kerryn Pennell,1,2 Rosemary Purcell,1,2,11 Debra Rickwood,14,15 Swaran P. Singh,16 Stephen J. Wood,1,2,17 Alison Yung,1,2 Patrick D. McGorry1,2 1. Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia 2. Centre for Youth Mental Health, University of Melbourne, Parkville, Australia 3. Department of Psychology, University of Oregon, Eugene, US 4. Department of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland 5. Transitions to Adulthood Center for Research, Systems and Psychosocial Advances Research Center, Department of Psychiatry, University of Massachusetts Medical School, Shrewsbury, US 6. School of Psychology, University College Dublin, Dublin 4, Ireland 7. Youth Mental Health Team, Brain and Mind Centre, University of Sydney, Sydney, Australia 8. Department of Psychiatry, McGill University, Montreal, Canada 9. Prevention and Early Intervention Program for Psychosis (PEPP), Douglas Mental Health University Institute, Montreal, Canada 10. ACCESS Open Minds (Canadian youth mental health services research network), Douglas Mental Health University Institute, Montreal, Canada 11.
  • 28/01/2021 1 Cannabis Myths and Facts

    28/01/2021 1 Cannabis Myths and Facts

    28/01/2021 Cannabis Myths and Facts Professor Mary Cannon Department of Psychiatry RCSI University of Medicine and Health Sciences Ireland 1 A developmental approach to mental health 2 the services Early Child & Adult Intervention Adolescent Psychiatry Psychiatry 3 1 28/01/2021 Early Origins of “Adult” Mental Disorder Dunedin Multidisciplinary Health and Development Study Children born in 1972‐73 (N=1037) Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H‐L. (2000) Children’s self‐reported psychotic symptoms predict adult schizophreniform disorders: a 15‐year longitudinal study. Archives of General Psychiatry 57:1053‐1058 4 Childhood Disorders Adult Disorders 75% before age 18 3 5 7 9 11 13 15 18 26 5 Early Intervention & Prevention 6 2 28/01/2021 Lessons from oncology: Don’t try to cure it –just prevent it! Wired magazine, 2007 7 MODELS OF PREVENTION Tertiary Secondary Risk Intervention Intervention Primary (In/Out patient Prevention (Early interventions treatment of those (School based services for with disorder) interventions for psychosis) bullying). Opportunity 1. Opportunity 2. Opportunity 3. Age Overview see ‐ Arango et al. (2018). Cost effectiveness ‐ see Campion & Knapp, (2018) 8 Prevention Tertiary prevention 9 3 28/01/2021 Prevention Secondary prevention 10 Prevention Primary prevention 11 The first major study: Sweden, 1987 (CANNABIS AND SCHIZOPHRENIA: A longitudinal study of Swedish conscripts, Sven Andreasson et al, pg. 1483, The Lancet, Dec. 26, 1987) Relative risk of schizophrenia, based on uses at time of conscription (~ age 18) 7 6 5 4 3 2 1 0 Risk of schizophrenia Never used 1‐10 times 11‐50 times > 50 times 12 4 28/01/2021 Early Origins of “Adult” Mental Disorder Dunedin Multidisciplinary Health and Development Study Children born in 1972‐73 (N=1037) Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H‐L.
  • We Need to Talk About Prevention…

    We Need to Talk about Prevention….. Editorial linked to Rimvall et al (2020) Colm Healy BA MSc and Mary Cannon MD PhD FRCPsych Department of Psychiatry, Royal College of Surgeons in Ireland, Dublin Since the turn of the century the study of psychotic experiences in the general population has become a major paradigm in mental health research. We now know that psychotic experiences are a relatively prevalent phenomenon, particularly in children and adolescents (1). They do not occur randomly and are clustered with other psychopathology (2,-4), poor functioning (5,6) and suicidal thoughts and behaviours (4,7). .A systematic review (3) has shown that psychotic experiences in childhood and adolescence are associated with a four-fold increased risk of later psychotic disorder but that evidence for longitudinal associations with non-psychotic disorder is sparse. Recent work has shown that psychotic experiences by themselves appear to have low predictive values and low sensitivity for later psychotic disorder (8) and that a more nuanced approach is needed to harness the predictive power of psychotic experiences. 1 In this issue of the Journal, Rimvall and colleagues (9) exploit the power of the Danish national registries to answer some important questions about the prognostic value of childhood psychotic experiences for mental health disorder and treatment in adolescence. In particular, they are interested in examining the unique predictive power of psychotic experiences compared with researcher-diagnosed psychopathology for subsequent diagnoses and treatment. Using the Danish personal identification numbers, the researchers carried out record linkage between a national cohort of 11 year old children and two national registers: the Danish National Patient Register and the Prescription Database, to give information on outcomes up to age 17.
  • The Epidemiology of Schizophrenia Edited by Robin M

    The Epidemiology of Schizophrenia Edited by Robin M

    Cambridge University Press 052177540X - The Epidemiology of Schizophrenia Edited by Robin M. Murray, Peter B. Jones, Ezra Susser, Jim Van Os and Mary Cannon Frontmatter More information The Epidemiology of Schizophrenia For the first time in one volume, an international team of leading researchers and practitioners have come together to provide a comprehensive, contemporary, epidemiological overview of this multifaceted and mysterious disorder and address some of the age-old questions it raises. What is the genetic contribution to schizophrenia? Do pregnancy and birth complications increase the risk for schizophrenia? Is the incidence of schizophrenia decreasing? Why is the rate higher among immigrants and in those born in cities? Controversial issues such as the validity of dimen- sional classifications of schizophrenia and the continuum between psychosis and ‘normality’ are explored in depth. Separate chapters are devoted to topics of particular relevance to schizophre- nia such as suicide, violence and substance abuse. Drawing together the findings from the social, genetic, developmental and classical epidemi- ology of schizophrenia, this text will prove an invaluable resource for both clinicians and researchers. Robin M. Murray is Professor of Psychiatry at the Institute of Psychiatry in London and heads the largest psychiatric research department in Europe. He has co-authored eight books and over 500 research publications and is on the editorial board of numerous journals. He was President of the Association of European Psychiatrists (1994–96). Peter B. Jones is Professor of Psychiatry, University of Cambridge. He is on the editorial board of Psychological Medicine. Ezra Susser is Chair of the Department of Epidemiology at the Joseph L.
  • Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence

    Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence

    King’s Research Portal DOI: 10.1001/jamapsychiatry.2020.2459 Document Version Publisher's PDF, also known as Version of record Link to publication record in King's Research Portal Citation for published version (APA): Mongan, D., Föcking, M., Healy, C., Susai, S. R., Heurich, M., Wynne, K., Nelson, B., McGorry, P. D., Amminger, G. P., Nordentoft, M., Krebs, M. O., Riecher-Rössler, A., Bressan, R. A., Barrantes-Vidal, N., Borgwardt, S., Ruhrmann, S., Sachs, G., Pantelis, C., Van Der Gaag, M., ... McGuire, P. (2021). Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence. JAMA Psychiatry, 78(1), 77-90. https://doi.org/10.1001/jamapsychiatry.2020.2459 Citing this paper Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination, volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are again advised to check the publisher's website for any subsequent corrections. General rights Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights. •Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
  • A 15-Year Longitudinal Study

    A 15-Year Longitudinal Study

    ORIGINAL ARTICLE Children’s Self-Reported Psychotic Symptoms and Adult Schizophreniform Disorder A 15-Year Longitudinal Study Richie Poulton, PhD; Avshalom Caspi, PhD; Terrie E. Moffitt, PhD; Mary Cannon, MD; Robin Murray, MD; HonaLee Harrington, BS Background: Childhood risk factors for the develop- diagnosis at age 26 years (odds ratio, 16.4; 95% confi- ment of adult schizophrenia have proved to have only dence interval, 3.9-67.8). In terms of attributable risk, modest and nonspecific effects, and most seem unre- 42% of the age-26 schizophreniform cases in the lated to the adult phenotype. We report the first direct cohort had reported 1 or more psychotic symptoms at examination of the longitudinal relationship between psy- age 11 years. Age-11 psychotic symptoms did not pre- chotic symptoms in childhood and adulthood. dict mania or depression at age 26 years, suggesting specificity of prediction to schizophreniform disorder. Methods: We analyzed prospective data from a birth co- The link between child and adult psychotic symptoms hort (N=761), in which children were asked about de- was not simply the result of general childhood psycho- lusional beliefs and hallucinatory experiences at age 11 pathology. years, and then followed up to age 26 years. Structured diagnostic interviews were employed at both ages and self- Conclusion: These findings provide the first evidence report of schizophreniform symptoms was augmented by for continuity of psychotic symptoms from childhood to other data sources at age 26 years. adulthood. Results: Self-reported psychotic symptoms at age 11 years predicted a very high risk of a schizophreniform Arch Gen Psychiatry.